Olanzapine (CAS 132539-06-1) – Antipsychotic API

Olanzapine (CAS 132539-06-1) is a potent atypical antipsychotic API with a unique multi-receptor action mechanism. It modulates dopamine, serotonin, and other neurotransmitter systems in the brain, effectively alleviating positive and negative symptoms of psychotic disorders. Produced via strict quality-controlled processes, it ensures consistent purity, bioavailability, and stability, meeting international pharmaceutical standards.

This high-quality API is a key raw material for pharmaceutical manufacturers developing mental health medications. It is widely used in formulating drugs for schizophrenia, bipolar disorder, and related psychotic conditions. Its proven clinical efficacy, favorable safety profile, and reliable performance make it a preferred choice for mental health drug R&D and production. For pharmaceutical enterprises and research institutions, it provides a trusted solution to address unmet needs in psychiatric treatment.